Istituto ortopedico Rizzoli
Bologna, 40136, Italy
NCT Number: NCT03768076
single institution cases series review of histological and clinical data
Looking for future studies?
Notify MeAll sexes
Observational
Bologna, 40136, Italy
Investigators will review all the cases with a diagnosis of primary parosteal osteosarcoma treated at the Rizzoli Institute from 1900 up to 31 July 2018, retrospectively.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at baseline (Day0)
Investigators will exam the presence of progression (dedifferentiation) areas and the relationship of these factors to individual outcome.
Istituto Ortopedico Rizzoli
Other
Parosteal OsTeosarcoma: a Single Istitution Experience
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05515068
Bone Diseases, Bone Neoplasms
View Trial DetailsNCT05046314
Disease Attributes, Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsNCT01625351
Adenocarcinoma, Adenocarcinoma, Clear Cell
Memphis, Tennessee, United States
View Trial DetailsNCT01858168
Ewing Sarcoma, Myosarcoma
Boston, Massachusetts, United States
View Trial Details